Apollo PE leaders opine on 2023; Vestar bets you need help getting to sleep

A conversation with Michael Vaupen, managing director at Vestar Capital Partners, about its investment in Nox Health; David Sambur and Matt Nord, co-heads of private equity at Apollo, talk about the year ahead.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this